Kunle Odunsi, MD, PhD, FRCOG, FACOG
KUNLE ODUNSI, MD, PHD, FRCOG, FACOG, Deputy Director of Roswell Park Cancer Institute, has been appointed to the Transplantation, Tolerance, and Tumor (TTT) Immunology Study Section within the National Institutes of Health (NIH) Center for Scientific Review. The TTT section is the panel of peer reviewers who consider applications to the NIH for funding related to studies of immune-related transplant rejection, basic mechanisms of acquired immune tolerance, and studies of tumor immunology and vaccine development.
Dr. Odunsi, who is also Chair, Oncology at Roswell Park and Executive Director of the Institute’s Center for Immunotherapy, will serve on this prestigious federal panel for a 4-year term. Members are selected to this study section on the basis of their demonstrated competence and achievement in their scientific discipline as evidenced by the quality of research accomplishments; publications in scientific journals; and other significant scientific activities, achievements, and honors.
“We are honored to see one of our colleagues tapped for this prestigious and very important role,” said Roswell Park President and Chief Executive Officer Candace S. Johnson, PhD. “Kunle understands keenly the need to exchange ideas back and forth between basic science labs and the clinical centers where we make our newest and most innovative therapies available, and that perspective will make him an insightful and valued contributor to this panel’s discussions." ■